Seizure medications: A review for the primary care pediatrician

Clinical Pediatrics

Volumn 44, Issue 5, 2005, Pages 383-391

  Flomin, Olga ^a   Wield, Linda ^b   Kamat, Deepak ^a,c,d,e  

^a WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b WEST VIRGINIA UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c Institute of Medical Education   (United States)

^d Carman and Ann Adams Department of Pediatrics   (United States)

^e WAYNE STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

4 AMINOBUTYRIC ACID; ANTICONVULSIVE AGENT; BARBITA; BENZODIAZEPINE; CARBAMAZEPINE; CONTRACEPTIVE AGENT; CREATININE; CYTOCHROME P450; DAPAKENE; ETHOSUXIMIDE; FELBAMATE; GABAPENTIN; GABATRIL; GLUTAMATE DECARBOXYLASE; LAMOTRIGINE; LIOTHYRONINE; OXCARBAZEPINE; PHENOBARBITAL; PHENYTOIN; PYRIDOXINE; SODIUM; SOLFOTAN; THYROTROPIN; THYROXINE; TIAGABINE; TOPIRAMATE; TOPOMAX; UREA; VALPROIC ACID; VIGABATRIN; ZONISAMIDE; ZORONTIN;

ABDOMINAL CRAMP; ABDOMINAL PAIN; ABSENCE; AGRANULOCYTOSIS; ANEMIA; ANGIONEUROTIC EDEMA; ANOREXIA; APLASTIC ANEMIA; ASPHYXIA; ASTROCYTOMA; ATAXIA; BEHAVIOR DISORDER; BLOOD ANALYSIS; BONE MARROW TOXICITY; BRAIN DISEASE; BRAIN HEMORRHAGE; CENTRAL NERVOUS SYSTEM INFECTION; CHROMOSOME 2; CLONIC SEIZURE; COGNITION; COMPUTER ASSISTED TOMOGRAPHY; CRANIOPHARYNGIOMA; CREATININE BLOOD LEVEL; CYTOMEGALOVIRUS; DIABETES MELLITUS; DIARRHEA; DIPLOPIA; DIZZINESS; DROWSINESS; DRUG COST; DRUG HYPERSENSITIVITY; DRUG METABOLISM; EEG ABNORMALITY; ELECTROENCEPHALOGRAM; ELECTROLYTE DISTURBANCE; EPENDYMOMA; EPILEPSY; EPILEPTIC STATE; ESCHERICHIA COLI; FATIGUE; FOCAL EPILEPSY; GAIT DISORDER; GINGIVA HYPERPLASIA; GLIOMA; GRAND MAL SEIZURE; HEADACHE; HUMAN; HYPERACTIVITY; HYPERCHLOREMIC ACIDOSIS; HYPERTRICHOSIS; HYPOCALCEMIA; HYPOGLYCEMIA; HYPOXIA; INDIGESTION; INFANTILE SPASM; INJURY; INSOMNIA; ISCHEMIA; LENNOX GASTAUT SYNDROME; LETHARGY; LIOTHYRONINE BLOOD LEVEL; LIVER FAILURE; LIVER FUNCTION TEST; LIVER TOXICITY; MEDULLOBLASTOMA; MEMORY DISORDER; MENTAL CONCENTRATION; MENTAL DISEASE; METABOLIC DISORDER; MUSCLE WEAKNESS; MYOCLONUS SEIZURE; NAUSEA; NAUSEA AND VOMITING; NERVOUSNESS; NEUROIMAGING; NUCLEAR MAGNETIC RESONANCE IMAGING; NYSTAGMUS; PARESTHESIA; PATIENT COMPLIANCE; PHOTOSENSITIVITY; PINEAL BODY TUMOR; PSYCHOMOTOR DISORDER; PYRIDOXINE DEFICIENCY; RASH; RESPIRATORY SYNCYTIAL PNEUMOVIRUS; REVIEW; RICKETS; RUBELLA; SEIZURE; SERUM SICKNESS; SIDE EFFECT; SODIUM BLOOD LEVEL; SOMNOLENCE; SPEECH DISORDER; STEVENS JOHNSON SYNDROME; SUICIDAL BEHAVIOR; THROMBOCYTOPENIA; THYROTOXICOSIS; THYROTROPIN BLOOD LEVEL; THYROXINE BLOOD LEVEL; TONIC SEIZURE; TOXOPLASMOSIS; TREMOR; UREA NITROGEN BLOOD LEVEL; VERTIGO; VISUAL FIELD DEFECT; VISUAL IMPAIRMENT; WEIGHT REDUCTION;

AGE DISTRIBUTION; ANTICONVULSANTS; CHILD; CHILD, PRESCHOOL; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG ADMINISTRATION SCHEDULE; DRUG UTILIZATION; FEMALE; HUMANS; INFANT; MALE; PEDIATRICS; PHYSICIAN'S PRACTICE PATTERNS; PRIMARY HEALTH CARE; PROGNOSIS; RISK ASSESSMENT; SEIZURES; SEVERITY OF ILLNESS INDEX; SEX DISTRIBUTION; TREATMENT OUTCOME;

EID: 20944448584     PISSN: 00099228     EISSN: None     Source Type: Journal    
DOI: 10.1177/000992280504400502     Document Type: Review

References (32)

1. Warden CR, Zibulewsky J, Mace S, et al. Evaluation and management of febrile seizures in the out-of-hospital and emergency department settings. Ann Emerg Med. 2003;41(2):215-222.
2. Zupanc ML. Update on epilepsy in pediatric patients. Mayo Clin Proc. 1996; 71:899-916.
3. Kramer U. Epilepsy in the first year of life: a review. J Child Neurol. 1999; 14(8):485-489.
4. Hauser WA. The prevalence and incidence of convulsive disorders in children. Epilepsia. 1994;35(suppl 2):S1-S6.
5. Proposal for revised clinical and electroencephalographic classification of epileptic seizures. Commission on Classification and Terminology of the International League Against Epilepsy. Epilepsia. 1989;30:389-399.
6. Scotoni AE, Manreza ML, Guerreiro MM. Recurrence after a first unprovoked cryptogenic/idiopathic seizure in children: a prospective study from Sao Paolo, Brazil. Epilpsia. 2004; 45(2):166-170.
7. Berg AT, Shinnar S, Levy SR, Testa FM. Newly diagnosed epilepsy in children: presentation at diagnosis. Epilepsia. 1999;404(4):445-452.
8. Mizrahi EM. Neonatal seizures and neonatal epileptic syndromes. Neurol Clin. 2001;19:427-463.
9. Dreifus FE, Nordil DR. Classification of epilepsies in childhood. In: Pellock JM, Dodson WE, Bourgeois BFD, eds. Pediatric Epilepsy, 2nd ed. New York: Demos Medical Publishing; 2001;69-80.
10. Ferrie CD, De Marco P, Grunewald RA, et al. Video games induced seizures. J Neurol Neurosurg Psychiatry. 1994;57(8):925-931.
11. Hirtz D, Ashwal S, Berg A, et al. Practice parameter: evaluating a first non-febrile seizure in children. Report of the Quality Standards Subcommittee of the American Academy of Neurology, the Child Neurology Society and the American Epilepsy Society. Neurology. 2000;55(5):616-623.
12. Green SM, Rothrock SG, Clem KJ, et al. Can seizures be the sole manifestation of meningitis in febrile children? Pediatrics. 1993;92:527-534.
13. Maytal J, Krauss JM, Novak G, et al. The role of brain computed tomography in evaluating children with new onset seizures in the emergency department. Epilepsia. 2000;41(8):950-954.
14. Nypaver MM, Reynolds SL, Tanz RR, Davis AT. Emergency department laboratory evaluation of children with seizures: dogma or dilemma? Pediatr Emerg Care. 1992;8:13-16.
15. Alsaadi TM, Thieman C, Shatzel A, et al. Video-EEG telemetry can be a crucial tool for neurologist experienced in epilepsy when diagnosing seizure disorders. Seizure. 2004;13(1):32-34.
16. Hawash KY, Rosman NP. Do partial seizures predict an increased risk of seizure recurrence after antiepilepsy drugs are withdrawn? J Child Neurol. 2003;18(5):331-337.
17. French JA, Kanner AM, Bautista J, et al. Efficacy and tolerability of the new antiepileptic drugs 1: treatment of new onset epilepsy. Report of the Therapeutics and Technology Assessment Subcommittee and Quality Standards Subcommittee of the American Academ of Neurology an the American Epilepsy Society. Neurology. 2004;62(8):1261-1273.
18. Bergin AM, Connolly M. New anti-epileptic drug therapies. Neurol Clin. 2002;20(4):1163-1182.
19. Besag FM. Behavioral aspects of pediatric epilepsy syndrome. Epilepsy Behav. 2004;5(suppl 1):S3-S1.
20. Loring DW, Meador KJ. Cognitive side effects of antiepileptic drugs in children. Neurology. 2004;62(6):872-877.
21. French J, Smith M, Faught E, et al. Practice advisory: the use of felbamate in the treatment of patients with intractable epilepsy. Report of the quality standards subcommittee of the American Academy of Neurology and the American Epilepsy Society. Neurology. 1999;52:1540-1545.
22. Uvebrant P, Bauzienè R. Intractable epilepsy in children. The efficacy of lamotrigine treatment, including non-seizure-related benefits. Neuropediatrics. 1994;25:284-289.
23. Lee DO, Steingard RJ, Cesena M, et al. Behavioral side effects of gabapentin in children. Epilepsia. 1996;37:87-90.
24. Evans J. FDA warning: topiramate: metabolic acidosis in risk. Pediatric News. February 2004:37.
25. Markind JE. Topiramate: a new antiepileptic drug. Am J Health Syst Pharm. 1998;55(6):554-562.
26. Uldall P, Bulteau C, Pedersen SA, et al. Tiagabine adjunctive therapy in children with refractory epilepsy: a single-blind dose-escalating study. Epilepsy Res. 2000;42:159-168.
27. Glauser TA. Oxcarbazepine in the treatment of epilepsy. Pharmacotherapy 2001;21:904-919.
28. Hirai K, Kimiya S, Tabata K, et al. Selective mutism and obsessive compulsive disorders associated with zonisamide. Seizure. 2002;11:468-470.
29. French JA. Vigabatrin. Epilepsia. 1999;40(suppl 5):S11-S16.
30. White HS. Comparative anticonvulsant and mechanistic profile of the established and newer antiepileptic drugs. Epilepsia. 1999;40(suppl 5):55-510.
31. Arzimanoglu A. Treatment options in pediatric epilepsy syndrome. Epileptic Disorders. 2002;4(3):217-225.
32. Yu KT, Mills S, Thompson N, Conanan. Safety and efficacy of intravenous valproate in pediatric status epilipticus and acute repetitive seizures. Epilepsia. 2003;44(5):724-726.